This Ground Breaking Drug Delivery Technology Reduces Drug Exposure by 80%
4 Aug
2016
Written by Mike Elliott

This Ground Breaking Drug Delivery Technology Reduces Drug Exposure by 80% »

Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSEā„¢ technology.

Read more...
$PULM | Pulmatrix iSPERSE Provides Major Advance in Drug Delivery
18 Apr
2016
Written by Mike Elliott

$PULM | Pulmatrix iSPERSE Provides Major Advance in Drug Delivery »

Pulmatrix uses an approach, originally pioneered at Harvard and the Massachusetts Institute of Technology, that represents a major advancement in delivering drugs to the lungs of patients with pulmonary disease.

Read more...

Login

Lost your password?